NIH-funded research Sbir 2 grant

Creating a wearable device to detect opioid overdoses

Official title: Developing a wearable medical device to detect opioid overdose

Funded at Resilient Lifescience, INC. · NIH-11268256 · Data updated 2026-11-12

This study is testing a new wearable device that helps keep people safe from opioid overdoses by monitoring their breathing and sending alerts to loved ones or emergency services if there's a problem, making it a helpful tool for anyone at risk.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionResilient Lifescience, INC.
NIH-funded
Lab location1 site (Pittsburgh, UNITED STATES)
Project startSeptember 15, 2024
Project endAugust 31, 2025
Funding year2025
Award (this year)$54,944
NIH project number3R44DA060643-01S1
Project IDNIH-11268256 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with Opioid Use Disorder (OUD) who are at risk of overdose.

Less likely to help

Patients who do not have Opioid Use Disorder or are not at risk of opioid overdose may not benefit from this research.

What this research studies

This research focuses on developing a wearable medical device that can continuously monitor individuals at risk of opioid overdose. The device aims to detect signs of Opioid Induced Respiratory Depression (OIRD) and send emergency alerts to friends, family, or emergency services when an overdose is detected. By addressing the critical issue of overdose deaths occurring without bystanders present, this technology seeks to improve response times and save lives. The project also involves validating the business model for marketing this device to families and healthcare providers.

Why it matters

Potential benefit: If successful, this research could significantly reduce the number of fatal opioid overdoses by enabling timely intervention.

How similar studies have gone: While wearable devices for health monitoring are becoming more common, this specific approach to detecting opioid overdose is novel and has not been widely tested.

Where this research is happening

  • Resilient Lifescience, INC.
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Holden, Bradford a — Resilient Lifescience, INC.
  • Study coordinator: Holden, Bradford a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.